NIH to study allergic reactions to COVID-19 vaccines

Wednesday, 07. April 2021 16:07

The United States National Institute of Health announced on Wednesday it will be conducting clinical trials on adults to determine whether patients with pre-existing allergic reactions may severely respond to the Moderna or Pfizer-BioNTech COVID-19 vaccines.

"The public understandably has been concerned about reports of rare, severe allergic reactions to the Moderna and Pfizer-BioNTech COVID-19 vaccines. The information gathered during this trial will help doctors advise people who are highly allergic. [...] However, for most people, the benefits of COVID-19 vaccination far outweigh the risks," said Anthony Fauci, NIH director.

The trials come as global drug institutions and healthcare organizations look into the nature of side-effect reactions to the AstraZeneca vaccine, which reportedly caused blood clotting and fatalities among several vaccinees.

Related Links: Moderna Inc.Pfizer Inc.
Breaking the News / LH